Clinical Trial Update: Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the efficacy and safety of a fixed-dose combination tablet of alogliptin and metformin in adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin/metformin (alogliptin/metformin)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2016-11-28